From Asthma to Chronic Urticaria: Expanding Clinical Uses of...

أضاف وظيفة جديدة Health

2026-07-24 10:06:09 -

From Asthma to Chronic Urticaria: Expanding Clinical Uses of Omalizumab

The rising prevalence of allergic diseases and severe asthma is driving steady growth in the Omalizumab Injection Market. Omalizumab is a monoclonal antibody that targets immunoglobulin E (IgE) and is widely prescribed for moderate-to-severe allergic asthma, chronic spontaneous urticaria (chronic hives), and selected allergic conditions. According to WiseGuyReports, the global omalizumab...

0 التعليقات 0 المشاركات 7 مشاهدة 0 معاينة